ConductScience.org, home

Paper26907620

Stronger Uricosuric Effects of the Novel Selective URAT1 Inhibitor UR-1102 Lowered Plasma Urate in Tufted Capuchin Monkeys to a Greater Extent than Benzbromarone.

Ahn SO and 10 others. J Pharmacol Exp Ther, 2016. Cited by 53 papers, by iCite.

Cite this record

ConductScience Library. Stronger Uricosuric Effects of the Novel Selective URAT1 Inhibitor UR-1102 Lowered Plasma Urate in Tufted Capuchin Monkeys to a Greater Extent than Benzbromarone. Papers, record 26907620. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/26907620

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Stronger Uricosuric Effects of the Novel Selective URAT1 Inhibitor UR-1102 Lowered Plasma Urate in Tufted Capuchin Monkeys to a Greater Extent than Benzbromarone.
PubMed
Journal
J Pharmacol Exp Ther
PubMed
Year
2016
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
53
iCite
Relative citation ratio, by iCite
2.38
iCite
Revised in PubMed
2025-03-06
PubMed

Authors11

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Ahn SOSung Oh
2Ohtomo SShuichi
3Kiyokawa JJumpei
4Nakagawa TToshito
5Yamane MMizuki
6Lee KJKyoung June
7Kim KHKi Hwan
8Kim BHByung Ho
9Tanaka JJo
10Kawabe YYoshiki
11Horiba NNaoshi

Source PubMed

Download CSV of authors

Topics19

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
BenzbromaroneMajor topic
Organic Anion TransportersMajor topic
Organic Cation Transport ProteinsMajor topic
OxazinesMajor topic
PyridinesMajor topic
Uricosuric AgentsMajor topic
Animals
Cebus
Chemical and Drug Induced Liver Injury
Dose-Response Relationship, Drug
Female
HEK293 Cells
Humans
Male
Microsomes, Liver
Organic Anion Transport Protein 1
Organic Anion Transporters, Sodium-Independent
Protein Binding
Uric Acid

Source PubMed

Download CSV of topics

Cited by23

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 53 citations.

PMIDTitleJournalYearIn PapersSource
42387087Targeted Treatment for Hyperuricemia: The Drug Pipeline.Drugs Aging2026https://conductscience.org/library/papers/42387087PubMed
41340907Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Food Effects of Single and Multiple Oral Doses of ABP-671 in Healthy and Hyperuricemic Subjects.Drug Des Devel Ther2025https://conductscience.org/library/papers/41340907PubMed
41065961URAT1 and GLUT9 as drug targets in gout: progress in transporter-directed therapies and delivery technologies.Inflammopharmacology2025https://conductscience.org/library/papers/41065961PubMed
40882135Gut-kidney axis modulation by viable and inactivated Akkermansia muciniphila mitigates avian hyperuricemia through microbial-metabolic crosstalk.mSystems2025https://conductscience.org/library/papers/40882135PubMed
40850676Serum uric acid and its metabolism-a vital factor in the inflammatory transformation of cancer.J Adv Res2026https://conductscience.org/library/papers/40850676PubMed
40513003Impact of Renal Impairment on the Pharmacodynamic and Pharmacokinetic Profiles of Epaminurad, a Novel Uric Acid Transporter 1 Inhibitor.Clin Transl Sci2025https://conductscience.org/library/papers/40513003PubMed
40420308Efficacy and safety of epaminurad, a potent hURAT1 inhibitor, in patients with gout: a randomized, placebo-controlled, dose-finding study.Arthritis Res Ther2025https://conductscience.org/library/papers/40420308PubMed
39101063Binding uric acid: a pure chemical solution for the treatment of hyperuricemia.RSC Adv2024https://conductscience.org/library/papers/39101063PubMed
38674776Priestia megaterium ASC-1 Isolated from Pickled Cabbage Ameliorates Hyperuricemia by Degrading Uric Acid in Rats.Microorganisms2024https://conductscience.org/library/papers/38674776PubMed
38256226Establishment of Polydopamine-Modified HK-2 Cell Membrane Chromatography and Screening of Active Components from Plantago asiatica L.Int J Mol Sci2024https://conductscience.org/library/papers/38256226PubMed
37959834Discovery of Novel Biphenyl Carboxylic Acid Derivatives as Potent URAT1 Inhibitors.Molecules2023https://conductscience.org/library/papers/37959834PubMed
36248735Probiotic Limosilactobacillus fermentum GR-3 ameliorates human hyperuricemia via degrading and promoting excretion of uric acid.iScience2022https://conductscience.org/library/papers/36248735PubMed
36081938Review of Urate-Lowering Therapeutics: From the Past to the Future.Front Pharmacol2022https://conductscience.org/library/papers/36081938PubMed
34204277Modulation of Urate Transport by Drugs.Pharmaceutics2021https://conductscience.org/library/papers/34204277PubMed
33764849Limosilactobacillus fermentum JL-3 isolated from "Jiangshui" ameliorates hyperuricemia by degrading uric acid.Gut Microbes2021https://conductscience.org/library/papers/33764849PubMed
32547398Identification of Structural Features for the Inhibition of OAT3-Mediated Uptake of Enalaprilat by Selected Drugs and Flavonoids.Front Pharmacol2020https://conductscience.org/library/papers/32547398PubMed
31980978Dotinurad versus benzbromarone in Japanese hyperuricemic patient with or without gout: a randomized, double-blind, parallel-group, phase 3 study.Clin Exp Nephrol2020https://conductscience.org/library/papers/31980978PubMed
31257523Urate transport capacity of glucose transporter 9 and urate transporter 1 in cartilage chondrocytes.Mol Med Rep2019https://conductscience.org/library/papers/31257523PubMed
30868332Two- and three-dimensional QSAR studies on hURAT1 inhibitors with flexible linkers: topomer CoMFA and HQSAR.Mol Divers2020https://conductscience.org/library/papers/30868332PubMed
30110943Tetragonia tetragonoides (Pall.) Kuntze (New Zealand Spinach) Prevents Obesity and Hyperuricemia in High-Fat Diet-Induced Obese Mice.Nutrients2018https://conductscience.org/library/papers/30110943PubMed

See all 23 cited byDownload CSV of cited by

Genes3

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
SLC22A12116085PubTator's text mininghttps://conductscience.org/library/genes/116085NCBI Gene
SLC22A69356PubTator's text mininghttps://conductscience.org/library/genes/9356NCBI Gene
SLC22A89376PubTator's text mininghttps://conductscience.org/library/genes/9376NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/26907620

GET https://conductscience.org/api/papers/v1/26907620/cited_by?page=2